Skip to main content
JW HOLDINGS CORPORATION logo

JW HOLDINGS CORPORATION — Investor Relations & Filings

Ticker · 096760 ISIN · KR7096760004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 418 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 096760

About JW HOLDINGS CORPORATION

https://www.jw-holdings.co.kr/

JW HOLDINGS CORPORATION is a healthcare holding company that operates through specialized subsidiaries in pharmaceuticals, medical devices, and consumer health. The company develops, manufactures, and markets a diverse portfolio of products. Its pharmaceutical arm focuses on therapeutic prescription drugs with an original pipeline and specialized treatments for clinical markets. A core area of expertise is the production of infusion fluids, with a subsidiary specializing in IV solutions utilizing advanced, automated manufacturing processes from formulation to packaging. The medical device division provides sophisticated diagnostic imaging systems, including MRI and CT scanners, alongside specialized equipment such as infant care units. The holding company directly manages global operations, handling the export of raw materials, finished products, and integrated manufacturing systems for IV solutions.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is explicitly titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, contains full financial statements, business descriptions, segment revenues, production capacities, and management analysis. It is a comprehensive interim/quarterly financial report rather than a brief earnings release or just an announcement, matching the definition of an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 89% confidence The document is a preliminary (잠정) operating performance announcement for Q1 2026 published by JW홀딩스 via public disclosure. It provides headline financial figures (sales, operating profit, profit before tax, net profit) for the quarter versus prior periods, with no full financial statements or detailed analysis. This is a classic quarterly earnings release of key metrics, not a full interim report. Therefore it should be classified as an Earnings Release (ER). Q1 2026
2026-05-12 Korean
주요사항보고서(영업정지)(자회사의 주요경영사항)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement reporting a business suspension (영업정지) for a subsidiary company, JW중외제약(주). It includes details such as the suspension period, affected products, financial impact estimates, legal basis for the suspension, and board resolution date. The document is addressed to the Financial Services Commission and Korea Exchange, indicating a regulatory filing. The length is short (1777 characters) and it primarily serves as a notification of a regulatory event rather than a detailed financial report or management discussion. There are no financial statements or comprehensive financial analysis present. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a “주식등의 대량보유상황보고서(일반)” (Report on Large Shareholdings) filed under Korea’s Capital Markets law. It details the shareholding status and changes of the largest shareholder and related parties, including number of shares, percentage holdings, movements, and major contracts (e.g., share collateral loans). This is a statutory notification of significant share ownership changes crossing reporting thresholds. It directly corresponds to the “Major Shareholding Notification” category. Therefore, the correct classification is MRQ.
2026-04-22 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)
Regulatory Filings Classification · 80% confidence The document is a Korean stock exchange disclosure of a subsidiary’s major management matter regarding an in-licensing agreement. It does not present financial results (ER/IR/10-K), management or board changes (MANG), share issues (SHA/POS), dividends (DIV), or a solicitation/proxy (PSI), nor is it an audit, ESG, or M&A announcement. It is a general regulatory announcement of a material contract, so it falls into the fallback category “Regulatory Filings” (RNS).
2026-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 85% confidence The document is a detailed “주식등의 대량보유상황보고서(일반)” (Large Shareholding Status Report) under the Korean Capital Markets Act, showing a major shareholder’s changes in shareholding and related details. This corresponds exactly to a Major Shareholding Notification, not an earnings release, annual report, or board change. Therefore, the correct classification is MRQ.
2026-04-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.